Multinucleation associated DNA damage blocks proliferation in p53-compromised cells

Area of Science:

• Oncology
• Cell Biology
• Genetics

Background:

• Nuclear atypia is a common feature in cancer cells.
• The p53 pathway is frequently compromised in approximately 50% of human cancers.
• The functional consequences of different types of nuclear atypia remain incompletely understood.

Purpose of the Study:

• To investigate the immediate and long-term effects of nuclear atypia on cell fate.
• To determine the specific impact of multinucleation on cell proliferation in the context of p53 deficiency.
• To elucidate the molecular mechanisms by which multinucleation induces cell cycle arrest.

Main Methods:

• Single-cell tracking studies were employed to monitor cell behavior over time.
• Analysis of DNA damage response pathways, including 53BP1 foci formation and DNA repair.
• Assessment of transcriptional activity, protein accumulation, and cell cycle progression markers (e.g., phospho-Rb).

Main Results:

• Multinucleation, unlike other nuclear atypia, effectively blocks proliferation in p53-compromised cells.
• Multinucleation leads to increased 53BP1 nuclear bodies, indicating DNA damage.
• Persistent, unresolved DNA damage and a replication block were observed, causing a novel cell cycle arrest independent of replication stress, linked to mitotic lesions.

Conclusions:

• Multinucleation acts as a prohibitive form of nuclear atypia, inducing a unique cell cycle arrest via unresolved DNA damage from mitotic errors.
• The findings highlight the importance of distinguishing between protective and prohibitive nuclear atypia for therapeutic strategies.
• Understanding these mechanisms can help in limiting tumor heterogeneity and improving cancer treatment outcomes.